WEBSITE BSE:524564 NSE : GAYATRI BIO 18 May, 12:50
Market Cap ₹45 Cr.
Stock P/E -65.4
P/B -1.3
Current Price ₹5.7
Book Value ₹ -4.5
Face Value 10
52W High ₹11.8
Dividend Yield 0%
52W Low ₹ 4.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 |
Operating Profit | -0 | -0 | -0 | -0 | -0 | -1 | -0 | -0 | -0 | -0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -1 | -0 | -0 | -0 | -0 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -0 | -0 | -0 | -0 | -0 | -1 | -0 | -0 | -0 | -0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -1 | -0 | -0 | -0 | -0 |
Adjusted Earnings Per Share | -0 | -0 | -0 | -0.1 | -0 | -0.1 | -0 | -0 | -0 | -0 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 152 | 215 | 257 | 138 | 80 | 173 | 155 | 0 | 0 | 0 | 2 | 0 |
Other Income | 0 | 0 | 0 | 1 | 0 | 12 | 2 | 85 | 0 | 0 | 0 | 0 |
Total Income | 152 | 215 | 257 | 139 | 80 | 185 | 158 | 85 | 0 | 0 | 2 | 0 |
Total Expenditure | 140 | 202 | 241 | 163 | 129 | 197 | 159 | 1 | 0 | 0 | 2 | 0 |
Operating Profit | 12 | 13 | 16 | -24 | -49 | -12 | -2 | 84 | -0 | -0 | -1 | 0 |
Interest | 7 | 8 | 9 | 13 | 12 | 0 | 5 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 4 | 4 | 2 | 2 | 5 | 7 | 9 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 1 | 0 | -17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 1 | 1 | 5 | -39 | -83 | -19 | -16 | 84 | -0 | -0 | -1 | 0 |
Provision for Tax | -0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 1 | 1 | 4 | -39 | -83 | -19 | -16 | 84 | -0 | -0 | -1 | 0 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1 | 1 | 4 | -39 | -83 | -19 | -16 | 84 | -0 | -0 | -1 | 0 |
Adjusted Earnings Per Share | 0.2 | 0.3 | 0.8 | -6.3 | -10.5 | -2.4 | -2 | 10.7 | -0.1 | -0.1 | -0.1 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | -59% | -35% |
Operating Profit CAGR | 0% | NAN% | 0% | NAN% |
PAT CAGR | 0% | NAN% | 0% | NAN% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -38% | -7% | 26% | 1% |
ROE Average | 0% | 0% | 0% | 9% |
ROCE Average | -55% | -34% | -20% | -28% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 36 | 37 | 41 | 2 | -81 | -102 | -117 | -32 | -33 | -33 | -34 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 11 | 4 | 17 | 14 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Other Non-Current Liabilities | 1 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 70 | 134 | 82 | 124 | 184 | 246 | 260 | 34 | 34 | 34 | 34 |
Total Liabilities | 119 | 176 | 142 | 142 | 105 | 145 | 145 | 3 | 3 | 2 | 2 |
Fixed Assets | 53 | 49 | 47 | 46 | 40 | 47 | 68 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 2 | 2 | 7 | 8 | 8 | 10 | 3 | 0 | 0 | 0 | 0 |
Total Current Assets | 64 | 125 | 88 | 88 | 56 | 89 | 73 | 3 | 3 | 2 | 2 |
Total Assets | 119 | 176 | 142 | 142 | 105 | 145 | 145 | 3 | 3 | 2 | 2 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 2 | 1 | 1 | 3 | 1 | 0 | 1 | 0 | 0 |
Cash Flow from Operating Activities | 10 | 14 | 1 | -26 | -14 | -3 | -1 | 85 | -1 | -0 | -1 |
Cash Flow from Investing Activities | -3 | 0 | -7 | -1 | -1 | 0 | -0 | 0 | 0 | 0 | 0 |
Cash Flow from Financing Activities | -7 | -14 | 4 | 28 | 16 | 0 | 0 | -0 | -0 | -0 | 1 |
Net Cash Inflow / Outflow | 0 | 1 | -2 | 0 | 1 | -3 | -1 | 85 | -1 | -0 | -0 |
Closing Cash & Cash Equivalent | 1 | 2 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.18 | 0.27 | 0.77 | -6.27 | -10.49 | -2.43 | -1.97 | 10.72 | -0.06 | -0.06 | -0.13 |
CEPS(Rs) | 0.95 | 1.1 | 1.24 | -5.92 | -9.81 | -1.55 | -0.79 | 10.72 | -0.06 | -0.06 | -0.13 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 0.94 | 1.2 | 1.98 | -2.88 | -10.3 | -13 | -14.84 | -4.12 | -4.19 | -4.25 | -4.38 |
Core EBITDA Margin(%) | 7.41 | 5.76 | 5.74 | -17.96 | -61.76 | -13.76 | -2.33 | 0 | 0 | 0 | -46.07 |
EBIT Margin(%) | 5.02 | 4 | 5.33 | -18.81 | -89.2 | -10.93 | -6.95 | 0 | 0 | 0 | -46.07 |
Pre Tax Margin(%) | 0.36 | 0.61 | 1.81 | -28.03 | -103.71 | -11.04 | -9.97 | 0 | 0 | 0 | -47.72 |
PAT Margin (%) | 0.56 | 0.61 | 1.48 | -28.03 | -103.71 | -11.04 | -9.97 | 0 | 0 | 0 | -60.6 |
Cash Profit Margin (%) | 3.02 | 2.51 | 2.37 | -26.49 | -97.01 | -7.02 | -4 | 0 | 0 | 0 | -60.6 |
ROA(%) | 0.81 | 0.92 | 2.47 | -27.29 | -67.07 | -15.3 | -10.67 | 114.01 | -17.49 | -20.55 | -52.48 |
ROE(%) | 20.67 | 24.79 | 48.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ROCE(%) | 9.45 | 10.66 | 15.81 | -26.53 | -110.25 | -104.81 | 0 | 0 | -20.9 | -26.4 | -54.76 |
Receivable days | 85.11 | 117.09 | 95.58 | 116.09 | 139.89 | 45.53 | 59.38 | 0 | 0 | 0 | 80.8 |
Inventory Days | 34.61 | 29.71 | 41.24 | 96.03 | 146.4 | 89.24 | 119.44 | 0 | 0 | 0 | 0 |
Payable days | 59.68 | 115.15 | 102.99 | 84.7 | 392.59 | 252.02 | 575.35 | 0 | 0 | 0 | 78.46 |
PER(x) | 16.37 | 15.91 | 11.31 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 |
Price/Book(x) | 3.07 | 3.51 | 4.42 | -3.19 | -1.6 | -0.51 | -0.14 | -0.32 | -1.54 | -4.41 | -1.64 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.62 | 0.44 | 0.51 | 1.23 | 3.01 | 0.91 | 0.32 | 0 | 0 | 0 | 55.25 |
EV/Core EBITDA(x) | 7.81 | 7.18 | 8.39 | -7.14 | -4.91 | -13.21 | -32.87 | 0.53 | -172.05 | -368.7 | -119.94 |
Net Sales Growth(%) | 16.03 | 41.35 | 19.46 | -46.15 | -42.32 | 117.58 | -10.33 | -100 | 0 | 0 | 0 |
EBIT Growth(%) | 66.61 | 10.86 | 59.16 | -282.87 | -173.54 | 73.33 | 43.04 | 882.31 | -100.59 | 0.12 | -54.92 |
PAT Growth(%) | 131.94 | 51.08 | 190.52 | -1084.89 | -113.42 | 76.84 | 19 | 644.73 | -100.59 | 0.26 | -103.69 |
EPS Growth(%) | 131.93 | 51.11 | 190.48 | -911.87 | -67.35 | 76.84 | 19 | 644.72 | -100.59 | 0.16 | -103.65 |
Debt/Equity(x) | 1.41 | 1.21 | 1.4 | 43.47 | -1.39 | -1.05 | -0.3 | -1.08 | -1.06 | -1.05 | -1.03 |
Current Ratio(x) | 0.91 | 0.94 | 1.07 | 0.7 | 0.3 | 0.36 | 0.28 | 0.09 | 0.07 | 0.06 | 0.05 |
Quick Ratio(x) | 0.74 | 0.76 | 0.63 | 0.41 | 0.16 | 0.13 | 0.11 | 0.09 | 0.07 | 0.06 | 0.05 |
Interest Cover(x) | 1.08 | 1.18 | 1.51 | -2.04 | -6.15 | -101.32 | -2.29 | 0 | -496.4 | -1652.67 | -27.83 |
Total Debt/Mcap(x) | 3.43 | 2.07 | 1.29 | 1.68 | 0.87 | 2.05 | 2.12 | 3.35 | 0.69 | 0.24 | 0.63 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 68.4 | 68.4 | 52.05 | 40.62 | 40.62 | 40.62 | 40.62 | 40.62 | 40.62 | 40.62 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 24.14 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 | 0.66 |
Public | 7.46 | 30.94 | 47.29 | 58.72 | 58.72 | 58.72 | 58.72 | 58.72 | 58.72 | 58.72 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 5.39 | 5.39 | 4.1 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 | 3.2 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 1.9 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Public | 0.59 | 2.44 | 3.73 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 | 4.63 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 | 7.88 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About